ALPINE GROUP PARTNERS, LLC.

Lobbying for AMGEN

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 3

Taxation/Internal Revenue Code

International tax developments

Trade (domestic/foreign)

Tariffs

Medicare/Medicaid

Issues related to Part D rebates Proposals related to drug pricing, drug price transparency, PBMs Implementation of the Inflation Reduction Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.